机构：[1]Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China四川省人民医院[2]Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院
National Natural Science Foundation of China (NSFC) [81702286]; Research Fund of Science & Technology Department of Sichuan Province [2021YJ0134, 2018JY0652]; Open Project of Radiation Oncology Key Laboratory of Sichuan Province [2020FSZLX04]
第一作者机构：[1]Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Peng Xuerun,Peng Qian,Zhong Lei.Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy[J].SIGNAL TRANSDUCTION AND TARGETED THERAPY.2021,6(1):doi:10.1038/s41392-021-00616-1.
APA：
Peng, Xuerun,Peng, Qian&Zhong, Lei.(2021).Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy.SIGNAL TRANSDUCTION AND TARGETED THERAPY,6,(1)
MLA：
Peng, Xuerun,et al."Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy".SIGNAL TRANSDUCTION AND TARGETED THERAPY 6..1(2021)
医学